Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Phenotype, function and clinical implications of myeloid-derived suppressor cells in cancer patients
Paola Filipazzi, Veronica Huber, Licia Rivoltini
Cancer Immunology Immunotherapy (2011) Vol. 61, Iss. 2, pp. 255-263
Closed Access | Times Cited: 241

Showing 1-25 of 241 citing articles:

History of myeloid-derived suppressor cells
James E. Talmadge, Dmitry I. Gabrilovich
Nature reviews. Cancer (2013) Vol. 13, Iss. 10, pp. 739-752
Open Access | Times Cited: 1063
Immune cell infiltration as an indicator of the immune microenvironment of pancreatic cancer
Y Ino, Rie Yamazaki–Itoh, Kazuaki Shimada, et al.
British Journal of Cancer (2013) Vol. 108, Iss. 4, pp. 914-923
Open Access | Times Cited: 772
Frequencies of circulating MDSC correlate with clinical outcome of melanoma patients treated with ipilimumab
Christiane Meyer, Laurène Cagnon, Carla Costa-Nunes, et al.
Cancer Immunology Immunotherapy (2013) Vol. 63, Iss. 3, pp. 247-257
Open Access | Times Cited: 519
Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
Guocan Wang, Xin Lü, Prasenjit Dey, et al.
Cancer Discovery (2015) Vol. 6, Iss. 1, pp. 80-95
Open Access | Times Cited: 454
Fates of CD8+ T cells in Tumor Microenvironment
Nomathamsanqa Resegofetse Maimela, Shasha Liu, Yi Zhang
Computational and Structural Biotechnology Journal (2018) Vol. 17, pp. 1-13
Open Access | Times Cited: 416
Depression and postoperative complications: an overview
Mohammed M. Ghoneim, Michael W. O’Hara
BMC Surgery (2016) Vol. 16, Iss. 1
Open Access | Times Cited: 401
Doxorubicin Eliminates Myeloid-Derived Suppressor Cells and Enhances the Efficacy of Adoptive T-Cell Transfer in Breast Cancer
Darya Alizadeh, Malika Trad, Neale T. Hanke, et al.
Cancer Research (2013) Vol. 74, Iss. 1, pp. 104-118
Open Access | Times Cited: 371
The Role of Myeloid-Derived Suppressor Cells (MDSC) in Cancer Progression
Viktor Umansky, C Blattner, Christoffer Gebhardt, et al.
Vaccines (2016) Vol. 4, Iss. 4, pp. 36-36
Open Access | Times Cited: 365
Interleukin-1 Beta—A Friend or Foe in Malignancies?
Rebekka Bent, Lorna Moll, Stephan Grabbe, et al.
International Journal of Molecular Sciences (2018) Vol. 19, Iss. 8, pp. 2155-2155
Open Access | Times Cited: 360
High-dimensional analysis of the murine myeloid cell system
Burkhard Becher, Andreas Schlitzer, Jinmiao Chen, et al.
Nature Immunology (2014) Vol. 15, Iss. 12, pp. 1181-1189
Closed Access | Times Cited: 339
Myeloid Cells and Related Chronic Inflammatory Factors as Novel Predictive Markers in Melanoma Treatment with Ipilimumab
Christoffer Gebhardt, Alexandra Sevko, Huanhuan Jiang, et al.
Clinical Cancer Research (2015) Vol. 21, Iss. 24, pp. 5453-5459
Open Access | Times Cited: 330
Immune Monitoring of the Circulation and the Tumor Microenvironment in Patients with Regionally Advanced Melanoma Receiving Neoadjuvant Ipilimumab
Ahmad A. Tarhini, Howard Edington, Lisa H. Butterfield, et al.
PLoS ONE (2014) Vol. 9, Iss. 2, pp. e87705-e87705
Open Access | Times Cited: 284
Myeloid derived suppressor cells – a new therapeutic target in the treatment of cancer
Robert Wesolowski, Joseph Markowitz, William E. Carson
Journal for ImmunoTherapy of Cancer (2013) Vol. 1, Iss. 1, pp. 10-10
Open Access | Times Cited: 281
Recent advances on the role of tumor exosomes in immunosuppression and disease progression
Paola Filipazzi, Maja Bürdek, Antonello Villa, et al.
Seminars in Cancer Biology (2012) Vol. 22, Iss. 4, pp. 342-349
Open Access | Times Cited: 266
The New Era of Cancer Immunotherapy: Targeting Myeloid-Derived Suppressor Cells to Overcome Immune Evasion
Paola De Cicco, Giuseppe Ercolano, Angela Ianaro
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 257
Increased Myeloid-Derived Suppressor Cells in Gastric Cancer Correlate with Cancer Stage and Plasma S100A8/A9 Proinflammatory Proteins
Linda Wang, Esther Wei Yin Chang, Siew Cheng Wong, et al.
The Journal of Immunology (2012) Vol. 190, Iss. 2, pp. 794-804
Closed Access | Times Cited: 242
Myeloid-Derived Suppressor Cells Predict Survival of Patients with Advanced Melanoma: Comparison with Regulatory T Cells and NY-ESO-1- or Melan-A–Specific T Cells
Benjamin Weide, Alexander Martens, Henning Zelba, et al.
Clinical Cancer Research (2013) Vol. 20, Iss. 6, pp. 1601-1609
Open Access | Times Cited: 242
Increase in CD14+HLA-DR−/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis
Fumitaka Arihara, Eishiro Mizukoshi, Masaaki Kitahara, et al.
Cancer Immunology Immunotherapy (2013) Vol. 62, Iss. 8, pp. 1421-1430
Open Access | Times Cited: 240
CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer
Jieyao Li, Liping Wang, Xinfeng Chen, et al.
OncoImmunology (2017) Vol. 6, Iss. 6
Open Access | Times Cited: 240
Metformin-Induced Reduction of CD39 and CD73 Blocks Myeloid-Derived Suppressor Cell Activity in Patients with Ovarian Cancer
Lifeng Li, Liping Wang, Jieyao Li, et al.
Cancer Research (2018) Vol. 78, Iss. 7, pp. 1779-1791
Open Access | Times Cited: 232
Tadalafil Reduces Myeloid-Derived Suppressor Cells and Regulatory T Cells and Promotes Tumor Immunity in Patients with Head and Neck Squamous Cell Carcinoma
Donald T. Weed, Jennifer L. Vella, Isildinha M. Reis, et al.
Clinical Cancer Research (2014) Vol. 21, Iss. 1, pp. 39-48
Open Access | Times Cited: 231
Antitumor Effect of Paclitaxel Is Mediated by Inhibition of Myeloid-Derived Suppressor Cells and Chronic Inflammation in the Spontaneous Melanoma Model
Alexandra Sevko, Tillmann Michels, Melissa Vrohlings, et al.
The Journal of Immunology (2013) Vol. 190, Iss. 5, pp. 2464-2471
Open Access | Times Cited: 217
SOX2 Is the Determining Oncogenic Switch in Promoting Lung Squamous Cell Carcinoma from Different Cells of Origin
Giustina Ferone, Ji‐Ying Song, Kate D. Sutherland, et al.
Cancer Cell (2016) Vol. 30, Iss. 4, pp. 519-532
Open Access | Times Cited: 214
Fecal microbiota transplantation plus anti-PD-1 immunotherapy in advanced melanoma: a phase I trial
Bertrand Routy, John Lenehan, Wilson H. Miller, et al.
Nature Medicine (2023) Vol. 29, Iss. 8, pp. 2121-2132
Closed Access | Times Cited: 201
On the origin of myeloid-derived suppressor cells
Camilla Rydberg Millrud, Caroline Bergenfelz, Karin Leandersson
Oncotarget (2016) Vol. 8, Iss. 2, pp. 3649-3665
Open Access | Times Cited: 187
Page 1 - Next Page

Scroll to top